Background/Objectives:(P)rehabilitation, comprising structured exercise, nutritional optimisation, and/or psychological support delivered pre- or postoperatively, has demonstrated efficacy in improving outcomes across the cancer care continuum. However, access remains limited. Technology-enabled (p)rehabilitation offers a novel solution with the potential to enhance equity and continuity of care. This systematic review aimed to evaluate the efficacy of technology-enabled (p)rehabilitation on perioperative and patient-reported outcomes among individuals undergoing thoracic and/or abdominopelvic cancer surgery.Methods:Six databases were search from inception to October 2024. Eligible studies were randomised controlled trials (RCTs) comparing technology-enabled (p)rehabilitation with usual care, placebo, or non-technology-based interventions in adults undergoing thoracic and/or abdominopelvic cancer surgery. Outcomes included postoperative complications, hospital readmissions, hospital length of stay (LOS), quality of life (QoL), pain, anxiety, depression, fatigue, distress, and satisfaction. Higher scores indicated improved QoL or worse symptom severity. Risk of bias was assessed using the revised Cochrane tool, and evidence strength was determined using GRADE methodology. Relative risks (RR) and mean differences (MD) were calculated using random-effects meta-analysis.Results:Seventeen RCTs (18 publications, n = 1690) were included. Trials most commonly evaluated application-based platforms (n = 8) and the majority exhibited some risk of bias. Technology-enabled (p)rehabilitation was associated with a significant reduction in LOS (MD = 1.33 days; 95% CI: 0.59–2.07; seven trials), and improvements in pain (MD = 6.12; 95% CI: 3.40–8.84; four trials), depression (MD = 2.82; 95% CI: 0.65–4.99; five trials), fatigue (MD = 10.10; 95% CI: 6.97–13.23; three trials) and distress (MD = 1.23; 95% CI: 0.30–2.16; single trial) compared with controls.Conclusions:Technology-enabled (p)rehabilitation shows promise in reducing LOS and improving selected patient-reported outcomes following thoracic and abdominopelvic cancer surgery. Although evidence is limited due to the small number of studies, modest sample sizes, methodological heterogeneity, and intervention variability, the overall findings justify further investigation. Large-scale, adequately powered clinical trials are required to confirm efficacy and guide clinical effectiveness and implementation studies.
背景/目标：预康复/康复（包括术前或术后提供的结构化运动、营养优化和/或心理支持）已被证明在改善癌症全程治疗结局方面具有成效，但其可及性仍然有限。技术辅助的预康复/康复提供了一种新颖的解决方案，有望提升医疗的公平性和连续性。本系统综述旨在评估技术辅助的预康复/康复对接受胸部和/或腹盆腔癌症手术患者围手术期及患者报告结局的疗效。
方法：检索了六个数据库从建库至2024年10月的文献。纳入的研究为随机对照试验，比较了技术辅助的预康复/康复与常规护理、安慰剂或非技术性干预在接受胸部和/或腹盆腔癌症手术的成人患者中的应用。结局指标包括术后并发症、再入院率、住院时长、生活质量、疼痛、焦虑、抑郁、疲劳、痛苦和满意度。评分越高表示生活质量改善或症状严重程度加重。使用修订版Cochrane工具评估偏倚风险，并采用GRADE方法学确定证据质量。使用随机效应荟萃分析计算相对风险和平均差。
结果：共纳入17项随机对照试验（18篇出版物，n = 1690）。试验最常评估基于应用程序的平台，且多数研究存在一定的偏倚风险。与对照组相比，技术辅助的预康复/康复与住院时长显著缩短以及疼痛、抑郁、疲劳和痛苦的改善相关。
结论：技术辅助的预康复/康复在缩短胸部和腹盆腔癌症手术后住院时长以及改善部分患者报告结局方面显示出潜力。尽管由于研究数量少、样本量有限、方法学异质性和干预措施多样性，证据尚不充分，但总体研究结果证明了进一步深入研究的必要性。需要开展大规模、足够效能的临床试验来确认其疗效，并为临床有效性和实施性研究提供指导。
肿瘤(癌症)患者之家